Considering cholesterol-reducing jabs? Inform your insurer so
Insurers may selectively cover emerging cholesterol medication. But those who have taken the injection as part of a clinical trial need to inform the insurer as their risk assessment changes.
About 15 percent of rural and 25-30 percent of urban population suffers from hypercholesterolemia – commonly referred to as high cholesterol, according to ICMR-INDIAB 2023 study.
Indians are taking to a new route to cholesterol management. While oral medications need to be taken everyday, injections, which have been found effective in reducing cholesterol by 55 percent, need to be taken only twice a year or a maximum of four times a year, based on the selected product.
About 15 percent of rural and 25-30 percent of urban population suffers from hypercholesterolemia – commonly referred to as high cholesterol, according to the ICMR-INDIAB 2023 study. Management
PRO PanoramaMoneycontrol Pro Panorama | A cure for consumption
Jul 8, 2024 / 03:43 PM IST
In this edition of Moneycontrol Pro Panorama: India looks to strengthen bond with Russia, new solutions for old agriculture sector...
Read Now
Are you a PRO subscriber? Sign In
What Do You Get
Ad free Experience
Seamless navigation, faster responses.
Expert Perspective
Explore 230+ exclusive editorials every month
+
Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights
40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events
Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters
Stay ahead with daily and weekly insights
Unlock exclusive discounts